Key result
Antidepressant persistence linked to ~36% lower odds of early antihypertensive nonpersistence in depressed patients.
Why the study?
Does treatment and persistence with antidepressant therapy improve early persistence to antihypertensive therapies in newly treated hypertension patients with comorbid depression?
Population
44,167 adults with hypertension who were new users of antihypertensive therapy in 2008 at Kaiser Permanente…
Comparison
Treatment for depression and 6-month persistence… vs No treatment or non-persistence with…
Design
Cohort
Follow-up
6 months
Authors
Loading...
Should not yet change practice in comorbid hypertension and depression; leaves open causal effects on antihypertensive adherence.
Cohort (n=44,167)
Does treatment and persistence with antidepressant therapy improve early persistence to antihypertensive therapies in newly treated hypertension patients with comorbid depression?
Effect estimate: OR 0.64 (95% CI 0.42-0.96)
In patients with comorbid hypertension and depression, persistence with antidepressant therapy is associated with better adherence to newly initiated antihypertensive medications.
Schmittdiel et al. (2014) conducted a cohort in Hypertension (n=44,167). Antidepressant therapy vs. No antidepressant therapy or non-persistence was evaluated on Early nonpersistence to antihypertensive therapies (OR 0.64, 95% CI 0.42-0.96). Persistence with antidepressant therapy in hypertensive patients with depression was associated with lower odds of early nonpersistence to antihypertensive medications (OR 0.64; 95% CI 0.42-0.96).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: